Skip To Main Content

Áreas terapeúticas

Descubra la más reciente actualización sobre la evidencia científica y los datos basados en la vida real que se han recopilado en el campo de la epidemiología. Esta información incluye detalles sobre la carga que estas enfermedades imponen a las personas y a la sociedad en general, así como los métodos de control que se están implementando para hacer frente a estas situaciones.

También se aborda el impacto económico que tienen enfermedades como asma grave, cardiovascular, dermatitis atópica, diabetes o enfermedades raras, etc., en la vida de nuestra población. Estos elementos son fundamentales para comprender la magnitud del problema y para desarrollar estrategias efectivas que ayuden a mejorar la salud pública.

Ordenar por

Patología

Limpiar filtro
  • Filtros
ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

Event rates and Risk Factors for Recurrent CV Events

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

Material diseñado por o para Sanofi Aventis de Colombia S.A., con fines educativos y dirigido a profesionales de la salud y personal administrativo del sector salud. Es estrictamente prohibido compartir este material con terceros.

Mayor información a disposición en el Departamento Médico:

En Colombia:

Sanofi-Aventis de Colombia S.A. Transversal 23 N° 97-73 - Edificio City Business. Piso 8. Bogotá D.C. Teléfono: 621 4400 - Fax: 744 4237

infomedica.colombia@sanofi.com

En Bolivia, Centro América y Caribe:

Sanofi-Aventis de Panamá S.A. Torre Evolution, piso 26, Calle 50 y Av. Aquilino de la Guardia Obarrio- Cuidad de Panamá, República de Panamá Telf.: (507) 382-9500. infomed.pac@sanofi.com

Sitio web: http://www.sanofi.com.pa/l/pa/sp/index.jsp

 

MAT-CO-2400825 V1.0 03/2024